Agency Information Collection Activities: Submission for OMB Review; Comment Request, 72423-72424 [2011-30214]
Download as PDF
<![CDATA[
sroberts on DSK5SPTVN1PROD with NOTICES
Federal Register / Vol. 76, No. 226 / Wednesday, November 23, 2011 / Notices
Contact Person: Caryn Cohen, Center
for Tobacco Products, Food and Drug
Administration, 9200 Corporate Blvd.,
Rockville, MD 20850, 1–(877) 287–1373
(choose option 4), email:
TPSAC@fda.hhs.gov, or FDA Advisory
Committee Information Line, 1–(800)
741–8138 ((301) 443–0572 in the
Washington, DC area), and follow the
prompts to the desired center or product
area. Please call the Information Line for
up-to-date information on this meeting.
A notice in the Federal Register about
last minute modifications that impact a
previously announced advisory
committee meeting cannot always be
published quickly enough to provide
timely notice. Therefore, you should
always check the Agency’s Web site and
call the appropriate advisory committee
hot line/phone line to learn about
possible modifications before coming to
the meeting.
Agenda: As part of the Tobacco
Products Scientific Advisory
Committee’s required report to the
Secretary of Health and Human
Services, the committee will continue
discussing issues related to the nature
and impact of the use of dissolvable
tobacco products on the public health,
including such use among children.
Discussion will include such topics as
the composition and characteristics of
dissolvable tobacco products, product
use, potential health effects, and
marketing.
FDA intends to make background
material available to the public no later
than 2 business days before the meeting.
If FDA is unable to post the background
material on its Web site prior to the
meeting, the background material will
be made publicly available at the
location of the advisory committee
meeting, and the background material
will be posted on FDA’s Web site after
the meeting. Background material is
available at https://www.fda.gov/
AdvisoryCommittees/Calendar/
default.htm. Scroll down to the
appropriate advisory committee link.
Procedure: On January 18, 2012, from
2 p.m. to 5 p.m., on January 19, 2012,
from 8 a.m. to 5 p.m., and on January
20, 2012 from 8 a.m. to 4 p.m., the
meeting is open to the public. Interested
persons may present data, information,
or views, orally or in writing, on issues
pending before the committee. Written
submissions may be made to the contact
person on or before January 4, 2012.
Oral presentations from the public will
be scheduled between approximately 3
p.m. and 4 p.m. on January 19, 2012.
Those individuals interested in making
formal oral presentations should notify
the contact person and submit a brief
statement of the general nature of the
VerDate Mar<15>2010
17:03 Nov 22, 2011
Jkt 226001
evidence or arguments they wish to
present, the names and addresses of
proposed participants, and an
indication of the approximate time
requested to make their presentation on
or before December 27, 2011. Time
allotted for each presentation may be
limited. If the number of registrants
requesting to speak is greater than can
be reasonably accommodated during the
scheduled open public hearing session,
FDA may conduct a lottery to determine
the speakers for the scheduled open
public hearing session. The contact
person will notify interested persons
regarding their request to speak by
December 28, 2011.
Closed Committee Deliberations: On
January 18, 2012, from 8 a.m. to 1 p.m.,
the meeting will be closed to permit
discussion and review of trade secret
and/or confidential commercial
information (5 U.S.C. 552b(c)(4)). This
portion of the meeting must be closed
because the Committee will be
discussing trade secret and/or
confidential data regarding products
provided by the tobacco companies.
Persons attending FDA’s advisory
committee meetings are advised that the
agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with physical
disabilities or special needs. If you
require special accommodations due to
a disability, please contact Caryn Cohen
at least 7 days in advance of the
meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our Web site at
https://www.fda.gov/
AdvisoryCommittees/
AboutAdvisoryCommittees/
ucm111462.htm for procedures on
public conduct during advisory
committee meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: November 16, 2011.
Jill Hartzler Warner,
Acting Associate Commissioner for Special
Medical Programs.
[FR Doc. 2011–30163 Filed 11–22–11; 8:45 am]
BILLING CODE 4160–01–P
PO 00000
72423
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2011–N–0780]
Bridging the Idea Development
Evaluation Assessment and LongTerm Initiative and Total Product Life
Cycle Approaches for Evidence
Development for Surgical Medical
Devices and Procedures; Public
Workshop; Correction
AGENCY:
Food and Drug Administration,
HHS.
Notice of public workshop;
correction.
ACTION:
The Food and Drug
Administration (FDA) is correcting a
notice that appeared in the Federal
Register of Monday, November 7, 2011
(76 FR 68769). The document
announced a public workshop entitled
‘‘Bridging the Idea Development
Evaluation Assessment and Long-Term
Initiative and Total Product Life Cycle
Approaches for Evidence Development
for Surgical Medical Devices and
Procedures.’’ The document was
published with an incorrect docket
number. This document corrects that
error.
FOR FURTHER INFORMATION CONTACT:
Joyce Strong, Office of Policy, Food and
Drug Administration, 10903 New
Hampshire Ave., Bldg. 32, Rm. 3208,
Silver Spring, MD 20993–0002, (301)
796–9148.
SUPPLEMENTARY INFORMATION: In FR Doc.
2011–28722, appearing on page 68769,
in the Federal Register of Monday,
November 7, 2011, the following
correction is made:
On page 68769, in the first column, in
the Docket No. heading, ‘‘[Docket No.
FDA 2011–N–0002]’’ is corrected to read
‘‘[Docket No. FDA–2011–N–0780]’’.
SUMMARY:
Dated: November 17, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011–30145 Filed 11–22–11; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Health Resources
and Services Administration (HRSA)
publishes abstracts of information
Frm 00037
Fmt 4703
Sfmt 4703
E:\FR\FM\23NON1.SGM
23NON1
72424
Federal Register / Vol. 76, No. 226 / Wednesday, November 23, 2011 / Notices
collection requests under review by the
Office of Management and Budget
(OMB), in compliance with the
Paperwork Reduction Act of 1995 (44
U.S.C. chapter 35). To request a copy of
the clearance requests submitted to
OMB for review, email
paperwork@hrsa.gov or call the HRSA
Reports Clearance Office on (301) 443–
1129.
The following request has been
submitted to the Office of Management
and Budget for review under the
Paperwork Reduction Act of 1995:
Proposed Project: National Sample
Survey of Nurse Practitioners (OMB No.
0915–xxxx)—[New]
The number of nurse practitioners
(NP) in the United States has been
growing rapidly over the past decade,
and continued growth is expected as the
annual number of graduates from NP
programs is at an all time high.
Furthermore, over the past 20 years,
financial and regulatory changes have
impacted the growth in NPs. The
expansion of health insurance under the
‘‘Patient Protection and Affordable Care
Act’’ (Pub. L. 111–148) will have an
impact on the demand for services. With
increasing numbers, NPs are poised to
play a critical role in the nation’s efforts
to expand access to health care services.
Despite the increasing number and
roles of NPs, unfortunately, there are
currently only limited, inconsistent data
available to policy makers and the
health care community. Accordingly, it
is difficult for these leaders to quantify
or fully understand the role of NPs in
the current (or future projected course of
the) health care system. In fact, it is
difficult to estimate with confidence the
number of NPs practicing in the U.S.
today.
The primary purpose of the Bureau of
Health Profession’s National Sample
Survey of Nurse Practitioners data
collection is to: (1) Improve estimates of
NPs providing services; (2) describe the
settings where NPs are working; (3)
identify the positions/roles in which
Number of
respondents
Instrument
NPs are working; (4) describe the
activities and services NPs are providing
in the healthcare workforce; (5)
determine the specialties in which NPs
are working; (6) explore NPs’
satisfaction with and perception of the
extent to which they are working to
their full scope of practice; and (7)
assess variations in practice settings,
positions, and practice patterns by
demographic and educational
characteristics.
The statutory provision that
authorizes this data collection is section
761(b) of the Public Health Service Act,
‘‘National Center for Health Care
Workforce Analysis,’’ which is codified
at 42 U.S.C. 294n(b). The information
obtained from this survey will
ultimately lead to more accurate and
complete national estimates of the
current NP supply as well as assist in
the development of more accurate NP
supply and demand projections.
The annual estimate of burden is as
follows:
Responses per
respondent
Total responses
Hours per
response
Total burden
hours
National Sample Survey of Nurse Practitioners ........
14,300
1
14,300
.33
4,719
Total ....................................................................
14,300
..........................
14,300
..........................
4,719
Written comments and
recommendations concerning the
proposed information collection should
be sent within 30 days of this notice to
the desk officer for HRSA, either by
email to
OIRA_submission@omb.eop.gov or by
fax to (202) 395–6974. Please direct all
correspondence to the ‘‘attention of the
desk officer for HRSA.’’
Dated: November 17, 2011.
Reva Harris,
Acting Director, Division of Policy and
Information Coordination.
[FR Doc. 2011–30214 Filed 11–22–11; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
sroberts on DSK5SPTVN1PROD with NOTICES
National Institutes of Health
Submission for OMB Review;
Comment Request Information
Program on the Genetic Testing
Registry
National Institutes of Health
(NIH), PHS, DHHS.
ACTION: Request for comments
AGENCY:
Under the provisions of
Section 3507(a) (1)(D) of the Paperwork
SUMMARY:
VerDate Mar<15>2010
17:03 Nov 22, 2011
Jkt 226001
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request to review and approve
the information collection listed below.
This proposed information collection
was previously published in the Federal
Register on July 27, 2011, (76 FR 44937)
and allowed 60 days for public
comment. Twelve public comments
were received. The purpose of this
notice is to allow an additional 30 days
for public comment. The National
Institutes of Health may not conduct or
sponsor, and the respondent is not
required to respond to, an information
collection that has been extended,
revised, or implemented on or after
October 1, 1995, unless it displays a
currently valid OMB control number.
Proposed Collection: Title: The
Genetic Testing Registry; Type of
Information Collection Request: New
collection; Need and Use of Information
Collection: Laboratory tests for more
than 2,000 genetic conditions are
available; however, there is no
centralized public resource that
provides information about the
availability and scientific basis of these
tests.
Recognizing the importance of making
this information easily accessible to
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
health care providers, patients,
consumers, and others, NIH is
developing a voluntary registry of
genetic tests. The Genetic Testing
Registry (GTR) will provide a
centralized, online location for test
developers, manufacturers, and
researchers to submit detailed
information about genetic tests. The
overarching goal of the GTR is to
advance the public health and research
in the genetic basis of health and
disease. As such, the Registry will have
several key functions, including (1)
Encouraging providers of genetic tests to
enhance transparency by publicly
sharing information about the
availability and utility of their tests; (2)
providing an information resource for
the public, including health care
providers, patients, and researchers, to
locate laboratories that offer particular
tests; and (3) facilitating genetic and
genomic data-sharing for research and
new scientific discoveries.
Frequency of Response: The
information will be submitted
voluntarily on a non-repeating,
continual basis. Submitters will be
requested to update their test
information at least once every 12
months.
E:\FR\FM\23NON1.SGM
23NON1
]]>Agencies
[Federal Register Volume 76, Number 226 (Wednesday, November 23, 2011)]
[Notices]
[Pages 72423-72424]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-30214]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Agency Information Collection Activities: Submission for OMB
Review; Comment Request
Periodically, the Health Resources and Services Administration
(HRSA) publishes abstracts of information
[[Page 72424]]
collection requests under review by the Office of Management and Budget
(OMB), in compliance with the Paperwork Reduction Act of 1995 (44
U.S.C. chapter 35). To request a copy of the clearance requests
submitted to OMB for review, email paperwork@hrsa.gov or call the HRSA
Reports Clearance Office on (301) 443-1129.
The following request has been submitted to the Office of
Management and Budget for review under the Paperwork Reduction Act of
1995:
Proposed Project: National Sample Survey of Nurse Practitioners (OMB
No. 0915-xxxx)--[New]
The number of nurse practitioners (NP) in the United States has
been growing rapidly over the past decade, and continued growth is
expected as the annual number of graduates from NP programs is at an
all time high. Furthermore, over the past 20 years, financial and
regulatory changes have impacted the growth in NPs. The expansion of
health insurance under the ``Patient Protection and Affordable Care
Act'' (Pub. L. 111-148) will have an impact on the demand for services.
With increasing numbers, NPs are poised to play a critical role in the
nation's efforts to expand access to health care services.
Despite the increasing number and roles of NPs, unfortunately,
there are currently only limited, inconsistent data available to policy
makers and the health care community. Accordingly, it is difficult for
these leaders to quantify or fully understand the role of NPs in the
current (or future projected course of the) health care system. In
fact, it is difficult to estimate with confidence the number of NPs
practicing in the U.S. today.
The primary purpose of the Bureau of Health Profession's National
Sample Survey of Nurse Practitioners data collection is to: (1) Improve
estimates of NPs providing services; (2) describe the settings where
NPs are working; (3) identify the positions/roles in which NPs are
working; (4) describe the activities and services NPs are providing in
the healthcare workforce; (5) determine the specialties in which NPs
are working; (6) explore NPs' satisfaction with and perception of the
extent to which they are working to their full scope of practice; and
(7) assess variations in practice settings, positions, and practice
patterns by demographic and educational characteristics.
The statutory provision that authorizes this data collection is
section 761(b) of the Public Health Service Act, ``National Center for
Health Care Workforce Analysis,'' which is codified at 42 U.S.C.
294n(b). The information obtained from this survey will ultimately lead
to more accurate and complete national estimates of the current NP
supply as well as assist in the development of more accurate NP supply
and demand projections.
The annual estimate of burden is as follows:
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Responses per Hours per Total burden
Instrument respondents respondent Total responses response hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
National Sample Survey of Nurse Practitioners...................... 14,300 1 14,300 .33 4,719
------------------------------------------------------------------------------------
Total.......................................................... 14,300 ............... 14,300 ............... 4,719
--------------------------------------------------------------------------------------------------------------------------------------------------------
Written comments and recommendations concerning the proposed
information collection should be sent within 30 days of this notice to
the desk officer for HRSA, either by email to OIRA_submission@omb.eop.gov or by fax to (202) 395-6974. Please direct all
correspondence to the ``attention of the desk officer for HRSA.''
Dated: November 17, 2011.
Reva Harris,
Acting Director, Division of Policy and Information Coordination.
[FR Doc. 2011-30214 Filed 11-22-11; 8:45 am]
BILLING CODE 4165-15-P
